Secondary somatic mutations restoring RAD51C and RAD51D associated with acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinoma

AOCS study group

Research output: Contribution to journal › Article › peer-review

134 Scopus citations

Fingerprint

Dive into the research topics of 'Secondary somatic mutations restoring RAD51C and RAD51D associated with acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences